Skin & Hair · Reference
Melanotan II Side Effects: Nausea, Flushing, Moles, and What to Report
This page is a practical reference: what to expect, when, what to watch on your skin, and what to report. What Melanotan II is, how it works and the full research history are in what is Melanotan II, and the comparison with its descendant is in PT-141 vs Melanotan II.

Treatments mentioned
The most common Melanotan II side effects in the human studies were nausea, facial flushing, a stretching and yawning sensation, reduced appetite, sleepiness at the top of the dose range, and in men spontaneous erections lasting on and off for one to five hours after a dose. They are dose-related and prescribers describe them as most noticeable at the start of a course. The side effect to take most seriously is on the skin: Melanotan II darkens existing moles and freckles, and case reports describe new and changing moles and a small number of melanoma diagnoses during or after use, without a causal link having been established. A personal history of melanoma or atypical moles rules it out.
This page is a practical reference: what to expect, when, what to watch on your skin, and what to report. What Melanotan II is, how it works and the full research history are in what is Melanotan II, and the comparison with its descendant is in PT-141 vs Melanotan II.
Melanotan II Side Effects
The short answer
| Side effect | How common | What to do |
|---|---|---|
| Nausea | The most commonly reported effect in the human studies, at most dose levels | Usually settles the same day; tell your care team if it is a problem |
| Facial flushing and warmth | Common, usually within an hour or two of a dose | Expected; report it if it does not settle |
| Stretching and yawning | Noted in every human study, often before erections | Transient; worth knowing about in advance |
| Reduced appetite | Recorded on the study side-effect questionnaires | Eat regular meals; it is not a weight treatment |
| Sleepiness | Reported at the top of the study dose escalation | Report it if it affects driving or work |
| Spontaneous erections (men) | Expected in the hours after a dose; on and off for one to five hours in the studies | An erection lasting more than four hours is an emergency |
| Darker moles and freckles | Expected; it is the pigment pathway working | Have moles examined before starting |
| New or changing moles | Described in case reports | Have any change in shape, border or texture looked at promptly |
The product this page covers:
| Product | What is in it | Typical printed directions | Price |
|---|---|---|---|
| Melanotan II | 5 mL multi-dose vial, Melanotan II 2 mg/mL (10 mg per vial) | 0.25 mL (25 units) subcutaneously once daily, Monday through Friday | $249/mo |
At 2 mg/mL, 0.25 mL is 0.5 mg of Melanotan II per dose (arithmetic from the vial strength, on a U-100 insulin syringe), and a vial holds 20 doses, about four weeks of weekday dosing. Your own directions are set by your physician after reviewing your intake and are printed on the vial. The price is all-in: medication, physician review, refill management and shipping, with no membership fee. Melanotan II is compounded by a PCAB-accredited, FDA-registered US 503A pharmacy. Compounded medications are not FDA approved.
Melanotan II Side Effects
Why Melanotan II causes the side effects it does
Melanotan II is a synthetic, ring-shaped analogue of alpha-melanocyte-stimulating hormone (alpha-MSH), the peptide skin releases after sun exposure. It is non-selective: it activates several melanocortin receptors at once rather than only the skin's MC1 receptor. Almost every side effect traces back to one of those receptors.
| Receptor | Where it sits | What it does | The side effect it explains |
|---|---|---|---|
| MC1R | Pigment cells (melanocytes) in the skin | Shifts production toward eumelanin, the brown-black pigment of a tan | Darker moles and freckles, uneven early pigmentation |
| MC4R | Hypothalamus and spinal cord | Initiates erections centrally and is linked to sexual desire | Spontaneous erections in men, a change in desire |
| MC3R and MC4R | Hypothalamus | Part of the body's satiety system | Reduced appetite |
| The melanocortin system broadly | Brain | A recognised effect seen in animals decades ago | The stretching and yawning complex |
That is why the side-effect list is longer than for a skin-only compound. It is also why taking Melanotan II for libido means accepting skin changes, and why taking it for a tan comes with the erection and appetite effects.
Melanotan II Side Effects
Common Melanotan II side effects
What the human studies recorded
Melanotan II has a better-characterised side-effect profile than most compounded peptides, because its human studies recorded side effects systematically. Those studies are small and from one research group in the 1990s: a three-person pigmentation pilot in Life Sciences in 1996, two ten-person, double-blind, placebo-controlled crossover studies in men with erectile dysfunction (Journal of Urology in 1998 and Urology in 2000), and a pooled review in the International Journal of Impotence Research in 2000. The consistent findings across them:
- Nausea. Reported at most dose levels, and severe after a minority of doses at the higher study dose.
- Facial flushing. Common, often with a feeling of warmth.
- Stretching and yawning. Every study noted it, typically before the erections began. It is transient and dose-related, and it is alarming only if you are not expecting it.
- Reduced appetite. A documented effect of the melanocortin system, recorded on the questionnaires. No study has looked at Melanotan II for appetite or weight, and it is not prescribed for that.
- Sleepiness. Reported at the top of the dose escalation.
- Spontaneous erections in men. Erections began without sexual stimulation and came and went for one to five hours after a dose.
The study authors described these effects as manageable. None of those studies tested repeated dosing over weeks or months, which is how Melanotan II is prescribed, so the long-run pattern comes from clinical experience rather than trials.
When they tend to appear
These are patterns described by prescribers, not trial endpoints, and they vary from person to person.
| Point in treatment | What is typical |
|---|---|
| The hour or two after an injection | Nausea, flushing, warmth, the stretching and yawning sensation; usually settling the same day |
| The hours after a dose, in men | Spontaneous erections, on and off |
| The first week | Mostly side effects rather than colour |
| Weeks one to four | Pigment showing first where pigment already is: moles, freckles, the face, the upper body |
| Repeated dosing | Prescribers describe the early effects as fading |
| After the vial | No withdrawal described; colour fades over weeks as skin cells turn over |
If nausea is a problem, tell your care team. Evening injection is a change prescribers commonly make for nausea, but it is a change to your directions, so it comes from your physician and appears on your vial. Never adjust the dose or timing yourself.
Melanotan II Side Effects
Melanotan II and your moles
This is the section that matters most.
What is expected
Melanotan II darkens existing moles and freckles. That is the pigment pathway doing what it does, and a mole that is simply darker is not by itself a warning sign. It is the reason your skin is examined before you start: you need a baseline to tell an expected darkening from a real change.
What the case reports describe
Case reports describe new moles appearing and existing ones changing during use. A small number, including reports in Dermatology in 2014 and the Australasian Journal of Dermatology in 2012, describe melanoma diagnosed during or shortly after a course. A 2017 review of the alpha-MSH analogue literature in the International Journal of Dermatology concluded that conclusive evidence of a causal link is lacking, but that the reports warrant caution and skin surveillance.
So the honest position is that nobody has shown Melanotan II causes melanoma, and nobody has shown it does not. It has not been studied over years, and it does not establish any change in melanoma risk in either direction.
What to watch for
Change What it means What to do A mole or freckle that is darker but otherwise unchanged Expected pigment effect Note it at your regular skin checks A mole that changes shape, border or texture Not explained by darkening Have it looked at promptly A new pigmented spot Needs a look Have it looked at promptly Check your skin regularly for as long as you are using it. It is the single most important practical point about Melanotan II. A darker tone is not sun protection: Melanotan II is not a sunscreen, the research does not describe it preventing sunburn or skin cancer, and nothing about it is a reason to use sunbeds or skip sunscreen.
Melanotan II Side Effects
Serious side effects: what the FDA keeps on file
Melanotan II was placed in Category 2 of the FDA's 503A bulk drug substances list in 2023, the category for substances flagged for significant safety concerns. It is no longer in Category 2: the FDA's current three-category list, updated 14 May 2026, does not include it there. The FDA's safety-risk page, current as of 22 April 2026, lists Melanotan II among substances previously in Category 2 and keeps its original note on file: a possible immunogenicity risk from aggregation or peptide impurities, and published case reports of melanoma, posterior reversible encephalopathy syndrome, sympathomimetic toxidrome and priapism.
Context matters for those reports. The toxicity case in Clinical Toxicology in 2012 involved a single self-administered dose of product bought online, many times larger than any reviewed direction. The priapism case in BMJ Case Reports in 2019 likewise involved self-sourced product. They are real events, and they are the reason the dose is set by a physician, printed on the vial, and drawn from a vial of known concentration.
The FDA has announced that its Pharmacy Compounding Advisory Committee will meet before the end of February 2027 to discuss Melanotan II for possible inclusion on the 503A bulks list, alongside LL-37, GHK-Cu, Dihexa and PEG-MGF. It remains legal to prescribe and dispense with a valid prescription, and it is not an FDA-approved drug.
Symptoms that need emergency care or a same-day call
| Symptom | What it may be | What to do |
|---|---|---|
| An erection lasting more than four hours | Priapism | Emergency care: call 911 or go to an emergency department |
| Severe headache with visual change or confusion | Needs urgent assessment | Call 911 |
| A racing heart with agitation and muscle pain | Possible sympathomimetic toxicity | Call 911 |
| Swelling of the face, lips or throat, widespread hives, trouble breathing | Serious allergic reaction | Call 911 first, then tell your care team |
| You think you injected far more than your directions | Possible overdose | Call Poison Control at 1-800-222-1222 and message your care team |
| An injection site that is hot, spreading or worse after 48 hours | Possible infection rather than irritation | Message your care team the same day |
| Nausea that stops you eating or drinking properly | More than the usual short-lived effect | Message your care team the same day |
Melanotan II Side Effects
Injection-site reactions
Melanotan II is injected under the skin into the abdomen or thigh, rotating sites. Because the signal is systemic, where you inject does not decide where you tan. Redness, mild soreness or a small lump that appears as you inject and settles within a day or two is the tissue responding to a needle and a volume of fluid. A lump that appears days later and is warm or spreading is different and needs a same-day message. Technique is covered in how to inject peptides safely. Use a fresh sterile syringe every time; Pepti ships sterile syringes and alcohol prep pads with every vial, and the vial ships refrigerated with ice packs.
Melanotan II Side Effects
When to message your care team
Message your care team, rather than waiting for your refill, if:
- nausea is stopping you eating properly or has not eased with repeated doses
- flushing, sleepiness or yawning is interfering with work or driving
- any mole changes shape, border or texture, or a new pigmented spot appears
- erections are frequent enough to be a problem, even if none has lasted four hours
- you start any new medication, particularly anything for erectile dysfunction or blood pressure
There is no established drug-interaction list for Melanotan II, because the trials that would produce one have not been run. That is why the intake asks for every medication you take and why a physician reviews it.
Melanotan II Side Effects
Who should not take Melanotan II
| Situation | Status |
|---|---|
| Personal history of melanoma or atypical moles | A stop, not a caveat |
| Existing pigmented lesions | Examined before starting |
| Very fair skin that burns rather than tans | Your physician may judge the balance is not there |
| Pregnancy or breastfeeding | Not used; safety data is absent |
| Taking medication for erectile dysfunction or blood pressure | Must be on your intake |
| Tested athletes | Check your sport's current prohibited list |
| Under 18 | Pepti prescribes to adults only |
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
Melanotan II Side Effects
Melanotan II vs PT-141 side effects
They overlap, because both act on the melanocortin family. PT-141 (bremelanotide) is a metabolite of Melanotan II developed for sexual desire. In its phase 3 trials nausea was reported by 40% of women against 1.3% on placebo, with flushing, injection-site reactions, headache and a transient blood-pressure rise after each dose, and focal skin darkening in about 1% at capped, as-needed dosing. Melanotan II adds yawning, spontaneous erections, appetite changes and the mole darkening that comes with tanning. Taking both stacks the same side effects, and no study has tested the combination. The full comparison is in PT-141 vs Melanotan II.
Melanotan II Side Effects
What the evidence shows, honestly
Melanotan II's short-term side effects are documented in randomised, placebo-controlled human studies, which is more than most compounded peptides have. The limits are real: the studies are small, from one group, used single doses or short courses, and did not follow anyone over repeated courses. Nothing establishes long-term safety, and the relationship between Melanotan II and melanoma is unresolved. The broader context is in are peptides safe long term and peptide side effects: what to watch for.
Melanotan II Side Effects
Where to get Melanotan II prescribed
Melanotan II cannot be bought legitimately without a prescription. Products sold "for research use only" have no accountable pharmacy behind their identity, purity, sterility or concentration, and the most serious case reports involved exactly that kind of product. The prescription route:
- Complete a free online intake covering your history, medications, skin history and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with ice packs, with sterile syringes and alcohol prep pads, and your directions printed on the vial.
- Your care team stays reachable for side effects and questions. Refills run every 28 days, one vial per fill.
Pepti is cash-pay and does not bill insurance, and prescribes Melanotan II in every state except Oklahoma, plus DC The step-by-step page is how to get Melanotan II prescribed online.
References
What this is based on.
References
- Dorr RT, Lines R, Levine N et al.. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study · Life Sci (1996) · PMID 8637402
- Wessells H, Fuciarelli K, Hansen J et al.. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study · J Urol (1998) · PMID 9679884
- Wessells H, Gralnek D, Dorr R et al.. Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction · Urology (2000) · PMID 11018622
- Wessells H, Levine N, Hadley ME et al.. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II · Int J Impot Res (2000) · PMID 11035391
- Habbema L, Halk AB, Neumann M, Bergman W. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review · Int J Dermatol (2017) · PMID 28266027
- Hjuler KF, Lorentzen HF. Melanoma associated with the use of melanotan-II · Dermatology (2014) · PMID 24355990
- Ong S, Bowling J. Melanotan-associated melanoma in situ · Australas J Dermatol (2012) · PMID 22724573
- Nelson ME, Bryant SM, Aks SE. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis · Clin Toxicol (Phila) (2012) · PMID 23121206
- Dreyer BA, Amer T, Fraser M. Melanotan-induced priapism: a hard-earned tan · BMJ Case Rep (2019) · PMID 30796078
- Zhang Y, Collazo R, Gao Y, Li G, Scarpace PJ. Intermittent MTII application evokes repeated anorexia and robust fat and weight loss · Peptides (2010) · PMID 20034526
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Melanotan II Side Effects, answered.
Nausea, facial flushing, a stretching and yawning sensation, reduced appetite and, at the top of the study dose range, sleepiness. In men, spontaneous erections on and off for one to five hours after a dose. They are dose-related and usually settle the same day.
Yes. It was the most commonly reported side effect in the human studies, often with flushing. Prescribers describe it as most noticeable at the start of a course and fading with repeated dosing. If it is a problem, tell your care team rather than changing your dose or timing yourself.
It darkens existing moles and freckles, which is expected. Case reports describe new and changing moles and a small number of melanoma diagnoses during or after a course. A 2017 review concluded a causal link has not been established but the reports warrant caution. Any mole that changes shape, border or texture should be looked at promptly.
The stretching and yawning complex is a recognised effect of melanocortin signalling, seen in animals decades before the human studies. Every human study noted it, usually before erections began. It is transient and dose-related.
It activates the MC4 receptor in the brain and spinal cord, which initiates erections centrally, independent of the blood-flow mechanism that sildenafil-type drugs act on. An erection lasting more than four hours is an emergency: call 911.
Yes, commonly, usually within an hour or two of an injection and settling the same day. Report it if it persists or comes with a racing heart, agitation or a severe headache.
The early effects usually come on within an hour or two of an injection and settle the same day, and prescribers describe them fading with repeated doses. There is no fixed timeline. Pigment fades over weeks after stopping as skin cells turn over.
An erection lasting more than four hours, a severe headache with visual change or confusion, a racing heart with agitation and muscle pain, or swelling of the face or throat or trouble breathing. Call 911. If you think you injected far more than your directions, call Poison Control at 1-800-222-1222.
No. It was placed in Category 2 in 2023 and is no longer in that category on the FDA's list updated 14 May 2026. The FDA keeps its original safety note on file, and its advisory committee is scheduled to discuss Melanotan II before the end of February 2027. It remains legal to prescribe and dispense with a valid prescription.
Reduced appetite was recorded as a side effect in the human studies and is a documented melanocortin effect in animals. No trial has studied Melanotan II for appetite or weight, and it is not a weight treatment.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. Your skin, not your blood, is what gets examined before you start. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.
